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Abstract  
A large number of polyphenolic and heterocyclic compounds, i.e. 4-methylcoumarins, 4-
methylthionocoumarins, xanthones, pyrazoles, pyrazolylacrylonitriles, flavones and isoflavones 
have been tested for their antioxidant activity towards NADPH-catalysed liver-microsomal lipid 
peroxidation with a view to establish their structure-activity relationship. Inhibition of 
microsomal lipid peroxidation by 7,8-dihydroxy-4-methylcoumarin (DHMC, 2) and 7,8-
diacetoxy-4-methylcoumarin (DAMC, 3) was intriguing. We also found that dihydroxy and 
diacetoxy derivatives of 4-methylthionocoumarin were more potent in comparison to the 
corresponding coumarin derivatives in inhibiting TNF-α induced expression of ICAM-1. The 
effect of nine different xanthones has been examined on the modulation of cytokine-induced 
expression of ICAM-1 in human endothelial cells. 1,4-Dihydroxyxanthone (10) showed 
enhanced antioxidant activity as well as the inhibition of the expression of cell adhesion 
molecules, such as ICAM-1, VCAM-1 and E-selectin on endothelial cells in a concentration and 
time dependent manner. Antioxidant activity of different pyrazoles and pyrazolylacrylonitriles 
and antiinvasive activity of flavones and isoflavones against solid tumors have also been studied.  
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Introduction 
 
Free radicals originate from a large variety of normal and pathological metabolic 
transformations, from host-defense against undesirable invasion (chemical or biological), and 
from host-response to a disturbance of the tissues integrity (due to trauma, cellular damage, etc.). 
The balance between formation and elimination of free radicals determines the overall stability 
of a living body. Free-radical chain reactions in the body are initiated mostly by Reactive Species 
[RS - molecules, ions, free-radicals; Reactive Oxygen Species (ROS) or Reactive Nitrogen 
Species (RNS)] possessing oxygen or nitrogen atom with an unpaired electron. If more RS are 
formed than needed for the normal redox-signaling and self-defense of the host, oxidative stress 
(OS) occurs leading to an oxidative cellular damage, even to cellular death. Free-radicals induce 
the cell damage by altering the biological activities of lipids, proteins, DNA and carbohydrates. 
A great deal of progress has been made in recent years in relating ageing to oxidation in 
biological cells. The ROS are basically involved in detoxification of invading organisms and 
chemicals, but stray ROS also initiate lipid peroxidation in healthy cells. Lipid peroxidation 
initiated by oxygen radicals eventually results in membrane degradation and cell death1 leading 
to diverse pathologies, such as Alzheimer's disease, atherosclerosis, diabetes, Parkinson's 
disease, etc.2 Thus, reduction of the rate of these life-limiting metabolic processes by use of 
chemicals has been a subject of current research.3-5 The negative effects of the RS may be 
diminished by limiting their formation (control over metabolic transformations and enzymes 
producing RS) through radical neutralization processes, for example by (a) recombination of the 
RS already formed (e.g. “radical scavenging”), and (b) altering the RS effects. Inhibitors of the 
RS synthesis [NADPH- oxidases, xanthine oxidase (XO) inhibitors, leukocytes’ antibodies, etc.] 
may also be administered. 
Antioxidants are the substances, which when present at low concentrations compared to 
those of an oxidisable substrate, significantly delay or prevent oxidation of that substrate. The 
key role of antioxidants is to intercept and react with free radicals so that cascade effect of ROS 
propagation is prevented by readily donating its proton to the ROS. Basically, the antoxidant 
property of a compound is attributed to its ability of (a) oxygen radical scavenging, (b) inhibiting 
cellular microsomal P-450-linked mixed function oxidation (MFO) reaction, and (c) suppressing 
the formation of ROS. Thus, antioxidants are considered as remedies to overcome the lethal 
action of oxygen free radicals. Polyphenolic compounds have drawn greater attention compared 
to any other class of natural products for their significant biological functions as antioxidants and 
anticarcinogens or antimutagens, which have led to their recognition as potential neutraceuticals. 
Among them, phenolics that include coumarins, xanthones, flavones, etc. have attracted 
considerable attention.  
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A criterion for a good antioxidant is that the compound should contain a highly labile 
hydrogen atom forming a radical, the radical formed should be stable and is not reactive so that it 
will not participate in the RS propagation step. Sterically hindered phenolic compounds satisfy 
most of the above-mentioned requirements. Thus, the anti-oxidant and radical scavenging effects 
of polyphenols are highly cited. We have investigated the antioxidant, anti-inflammatory and 
anti-invasive effects of a large number of polyphenolics, and heterocyclic compounds belonging 
to different classes. A review of our work in these areas is presented here.  
 
Coumarins 
 
Coumarins (known as 1,2-benzopyrones or o-hydroxycinnamic acid-8-lactones) comprise a very 
large class of phenolic derivatives found in plants and consist of fused benzene and α-pyrone 
rings. Coumarins have attracted intense interest in recent years because of their diverse 
pharmacological properties.  Among these properties, their antioxidant effects have been 
extensively examined. The pharmacological and biochemical properties, and therapeutic 
applications of simple coumarins depend upon their pattern of substitution. 4-Methylcoumarins 
are implicated to have several beneficial pharmacological effects.6,7
We, for the first time, have isolated 8-acetyl-7-hydroxy-6-methoxycoumarin and 8-
methoxycoumarin8 from Fraxinus floribunda leaves, trigoforin (3,4,7-trimethylcoumarin)9 from 
Trigonella foenumgraecum stems, troupin (4-methyl-6-hydroxy-7,8-dimethoxycoumarin)10 and 
trigocoumarin [3-(ethoxycarbonyl)methyl-4-methyl-5,8-dimethoxycoumarin]11 from Tamarix 
troupii and Trigonella foenumgraecum, respectively. The leaves of Tamarix troupii are 
pharmaceutically important and are used for the treatment of dysentery, chronic diarrhoea and 
leucoderma. In addition, the seeds of Trigonella foenumgraecum are used for curing colic, 
dysentery, diabetes and chronic cough 12. 
Unsubstituted coumarins appear to be toxic because of their oxidative decarboxylation, 
resulting in the formation of o-hydroxyphenylacetaldehyde or o-hydroxyphenyl acetic acid 
derivatives which form very stable complexes with heavy metals inside the body.13 On the other 
hand, 4-methylcoumarins are reluctant towards oxidative decarboxylation and hence, are non-
toxic.13 In the recent years, our laboratory is engaged in studying the chemistry and biological 
effects of 4-methylcoumarin derivatives 1.14,15 We have systematically studied the effect of 
acetoxy, hydroxy and methoxy substituents in a wide variety of 4-methylcoumarin derivatives on 
initiation, propagation and chain termination of lipid peroxidation in rat liver microsomes 
(Figure 1).16 
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Figure 1. Structures of compounds screened. 
 
The inhibitory effects of monohydroxy- or monoacetoxycoumarins were very marginal, 
while there was quantum jump in the potency of dihydroxy and diacetoxy derivatives 2-6 to 
retard the initiation of lipid peroxidation. 4-Methylcoumarins 2-6, having two hydroxy or two 
acetoxy groups in the benzenoid ring at positions ortho to each other, have shown very strong 
antioxidant and radical scavenging properties.16 These compounds could abolish nearly 90% of 
lipid peroxidation. In addition, these dihydroxy- and diacetoxycoumarins were found to possess 
the ability to terminate the radical chain reaction and propagation of lipid peroxidation along 
with excellent radical scavenging potency. We have proposed a mechanism of action for their 
antioxidant effect (Scheme 1).16 It is quite clear that such type of resonance stabilized radicals in 
differently substituted flavonoids are known to confer radical scavenging properties to 
flavonoids. We believe that there exists the possibility of the conversion of 7,8-diacetoxy-4-
methylcoumarin (DAMC, 3) to 7,8-dihydroxy-4-methylcoumarin (DHMC, 2) in the presence of 
the initiating free radical such as peroxy radical or superoxide radical through the formation of 
reactive ketene (Scheme 1). 
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Scheme 1. Proposed reaction of DAMC and DHMC showing radical structures. 
 
These properties of the coumarin derivatives highlight them as superior antioxidants. 
Investigations on several types of flavonoids allowed to conclude that the catechol moiety  
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We have also used the pH measurement techniques to study the mechanistic action of DAMC 
and DHMC to inhibit lipid peroxidation. These studies confirm the formation of a stable ADP-
Fe-inhibitor (e.g. ADP-Fe-DHMC) mixed ligand complex, thereby inhibiting the ROS which is 
responsible for lipid peroxidation.19 
 
Table 1. Radical scavenging potential of diacetoxy- and dihydroxy-4-methylcoumarins 
Compound Scavenging of DPPH IC50 (µM) 
7,8-Dihydroxy-4-methylcoumarin (2) 14 
7,8-Diacetoxy-4-methylcoumarin (3) 31 
7,8-Diacetoxy-3-ethoxycarbonylethyl-4- 
methylcoumarin (4) 85 
6,7-Diacetoxy-4-methylcoumarin (5) 31 
6,7-Diacetoxy-3-ethoxycarbonylethyl-4- 
methylcoumarin (6) 172 
Ascorbic acid (7) 35 
DPPH: Diphenylpicrylhydrazyl reagent 
 
Although polyphenolic compounds containing “free” hydroxyl groups (-OH) are known to be 
antioxidants, the antioxidant action of the acetoxy (-OAc) compound DAMC was intriguing 
(Table 2). Hence, pulse radiolysis studies were undertaken to explain the antioxidant action of 
DAMC. Accordingly, DAMC and DHMC were separately reacted with the system generating 
azide radicals and the resulting transient UV spectra were recorded.20 
 
Table 2. Scavenging of superoxide radical by DHMC and DAMCa
 Cytochrome C reduced 
(µmol/min.) 
Superoxide scavenging 
(no. of folds) 
Control 2730 0 
DHMC 633 4.31 
DAMC 793 3.44 
aSuperoxide radical generated during the reaction catalysed by xanthine oxidase is utilized for 
the scavenging action of the test compounds. The values expressed are mean of three 
experiments with variation <5%. 
 
The spectra of transient species obtained from DHMC and DAMC, produced on their 
reaction with azide radicals were studied thoroughly. We proposed that the mechanism of 
scavenging of reactive oxygen species (ROS) by DAMC and DHMC is quite similar. The results 
tabulated in Table 2 confirm the notion that both of these compounds 2 and 3 were found to 
scavenge superoxide radicals very efficiently. These results suggest that the free radical mediated 
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oxidation of DAMC and DHMC initially produce a radical cation that may lose an acetyl 
carbocation to produce phenoxy radical (Scheme 2).  
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Scheme 2. Comparison of azide free radical interactions with DHMC and DAMC. 
 
The root cause of inflammation is the increased expression of cell adhesion molecules 
(CAM) on the surface of endothelial cells which leads to indiscriminate infiltration of the 
leukocytes across the blood vessels causing inflammatory diseases. This increase is induced by 
various inflammatory mediators like TNF-α, IL-β, bacterial lipopolysaccharides, etc. In the 
recent past, some antioxidants have shown to downregulate the expression of intercellular cell 
adhesion molecule-1 (ICAM-1) on endothelial cells.21 In order to understand the mechanisms 
underlying the anti-inflammatory activities and for establishing structure-activity relationships, 
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we have synthesized different  derivatives of oxygenated and thiono-4-methylcoumarins and 
have studied their effects on TNF-α induced expression of ICAM-1 on endothelial cells and on 
NADPH-catalyzed rat liver microsomal lipid peroxidation.  Our data showed that dihydroxy and 
diacetoxy derivatives of thionocoumarins were more potent in comparison to the corresponding 
coumarin derivatives in inhibiting TNF-α induced expression of ICAM-1.  However, coumarin 
derivatives were more potent in comparison to the corresponding thionocoumarins in inhibiting 
microsomal lipid peroxidation.  We have also tested the intermediate compounds 7,8-
dibenzyloxy-4-methylcoumarin and 7,8-dibenzyloxy-4-methylthionocoumarin for their 
inhibitory activity on TNF-α induced ICAM-1 expression.  Our study indicated that dibenzyloxy-
4-methylthionocoumarin is better than dibenzyloxy-4-methylcoumarin. The mechanisms 
underlying the observed activities of coumarins and thionocoumarins have been investigated 
with reference to their structures, such structure-activity relationship studies may help in 
developing molecules with better anti-inflammatory and anti-oxidant activities.22
We have further extended our studies and synthesized a new series of 4-methylcoumarin 
derivatives bearing different functionalities viz., halo, unsaturated hydrocarbon chains, etc. They 
have been screened for evaluation of the antioxidant activities by β-carotene-linoleate model 
system. Theoretical values of Bond Dissociation Enthalpy (BDE) of these coumarins were 
compared with the antioxidant activity values calculated by β-carotene-linoleate model system.23 
According to this model system, the percent antioxidant activity decrease from dihydroxy to 
monohydroxy coumarins is consistent with the trend for BDE values and the antioxidant 
activities are comparable with BDE values (unpublished results from our Laboratories). 
We have reported the existence of a novel microsomal deacetylase in rat liver catalyzing 
deacetylation of diacetoxy 4-methylcoumarins.  A simple method was outlined for the enzyme 
assay based upon the quantification of the dihydroxy derivative by measuring the UV absorption 
of its complex with ADP and Fe3+ ions at 600 nm.  The enzyme was routinely assayed using 7,8-
diacetoxy-4-methylcoumarin (DAMC) as the substrate and demonstrated hyperbolic kinetics and 
yielded Km and Vmax values of 1250 µM and 500 units, respectively. The pH optimum was 
found to be 7.5 for the enzyme.  No DAMC deacetylase activity was found in hepatic cytosol 
and the enzyme activity was not discernible in extra hepatic tissues.24
We have discovered a membrane-bound enzyme catalyzing the transfer of acetyl groups from 
the acetyl donor 7,8-diacetoxy-4-methylcoumarin (DAMC) to glutathione S-transferase 3-3 
(GST3-3), termed Acetoxy Drug (DAMC):protein transacetylase (TAase). The purified enzyme 
was incubated with recombinant GST 3-3 subunit and DAMC, the modified protein was isolated 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in gel digested with 
trypsin and the tryptic digest was analyzed by mass spectrometry.  The N-terminus and six 
lysines, Lys-51, -82, -124, -181, -191 and -210, were found to be acetylated.  The acetylation of 
GST 3-3 described above was not observed in the absence of either DAMC or TAase. These 
results clearly establish the phenomenon of protein acetylation independent of acetyl CoA 
catalyzed by a hitherto unknown enzyme (TAase) utilizing a certain xenobiotic acetate (DAMC) 
as the active acetyl donor.25
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The investigations on the specificity for transacetylase (TAase) with respect to the number 
and positions of acetoxy groups on the benzenoid ring of coumarin molecule revealed that 
acetoxy groups in proximity to the oxygen heteroatom (at C-7 and C-8 positions) demonstrate a 
high degree of specificity to TAase.26
The cardinal role of the pyran ring carbonyl group in the acetoxy polyphenolic compounds 
for the acetoxy drug: protein transacetylase (TAase) activity was also proposed by us.  Hence, an 
attempt was made to examine  the effectiveness of substrate analogues of polyphenolic 
peracetate lacking pyran ring carbonyl group, such as 7-acetoxy-3,4-dihydro-2,2-
dimethylbenzopyran, catechin pentaacetate and hematoxylin pentaacetate as the substrates to 
TAase. No TAase activity appeared when these compounds were used as the substrates for 
TAase, thereby confirming the absolute requirement of the pyran carbonyl group for the catalytic 
activity of TAase.26  
We have also demonstrated that the acetoxy phenylcoumarins (having a phenyl ring instead 
of a methyl group at the C-4 position) and acetoxy dihydrocoumarins, when used as the 
substrates, yielded TAase activity, while the saturation of double bond at C-3 and C-4 position 
had no effect on the TAase activity.27  A comparison of the optimized structures of 7,8-
diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-phenylcoumarin suggested that the observed 
influence may be due to the out of plane configuration of the phenyl ring at C-4.27   
DAMC and other acetoxycoumarins, with no prerequisite for oxidative biotransformation 
have been reported to produce suicide inactivation of microsomal cytochrome P450-catalyzed 
formation of aflatoxin B1-8,9-epoxide that binds to DNA.  Parenteral administration of DAMC 
and other acetoxycoumarins to rats caused significant inhibition of AFB1 binding to  DNA in 
vivo as well as AFB1-induced micronuclei formation in bone marrow and lung  cells. These 
results highlight the antimutagenic potential of acetoxycoumarins.28-30
We have also found that another protein, i.e. hepatic NADPH cytochrome C reductase (an 
enzyme participating in the microsomal electron transport in cytochrome P-450 cycle) was 
shown to be remarkably activated by DAMC and acetoxy polyphenols unlike the inhibitory 
action of former on P-450 catalyzed oxidation. The catalytic activity of the enzyme enhanced 
nearly 600 % by 25 µM of DAMC after 10 min of pre-incubation. DAMC also proved to be 
effective in significantly enhancing the activity of NADPH cytochrome C reductase in vivo. 
DHMC, the deacetylated product of DAMC failed to irreversibly activate the enzyme. The 
activation effect of DAMC upon the enzyme was abolished by p-hydroxymercury benzoate.  The 
role of a transacetylase in transferring the acetyl group of DAMC to the amino acid(s) of the 
active site of NADPH cytochrome C reductase causing irreversible enzyme activation has been 
enunciated by us.27,31
An enhanced intracellular level of nitric oxide (NO) is essential to ameliorate several 
pathological conditions of heart and vasculature necessitating the activation of NOS. The 
enzymology of nitric oxide synthase (NOS) has revealed that NOS is a multidomain enzyme 
complex. There are four cofactors, namely 5,6,7,8-tetrahydrobiopterins (BH4), heme, FMN and 
FAD distributed over the oxygenase and reductase domains of NOS. The reductase domain 
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appears to be rate limiting in the formation of NO from arginine. We have reported the 
acetylation of the enzyme, endothelium nitric oxide synthase (eNOS) by polyphenolic 
peracetates (PA) catalyzed by the novel enzyme TAase discovered in our laboratory as an 
unambiguous way of activating NOS which results in the manifestation of its physiological 
actions. The human platelet was chosen as the experimental system in order to validate the 
aforementioned proposition. PA caused profound irreversible activation of platelet NADPH 
cytochrome c reductase mediated by TAase. The convincing biochemical evidences were 
presented to show that PA could cause acetylation of the reductase domain of NOS leading to the 
activation of eNOS in tune with their specificities to platelet TAase. As a result, the enhanced 
levels of NO due to activation of platelet eNOS by PA were found to inhibit the ADP-induced 
platelet aggregation. The studies highlighted for the first time the role of PA as the novel potent 
agent for enhancing the intracellular NO levels.32 The activation of NADPH cytochrome c 
reductase and intracellular NO levels and cytochrome P-450 linked MFO by acetoxy 
polyphenols were established as the TAase related biological effects. 
We have purified the TAase from rat liver microsomes to homogeneity and it exhibited the 
mol. wt. of 55 KDa. The N-terminal sequence showed 100 % homology with N-terminal 
sequence of mature calreticulin (CRT). The identity of TAase with CRT, an endoplasmic 
reticulum (ER) protein, was evidenced by the demonstration of the properties of CRT such as 
immunoreactivity with anti-calreticulin, binding to Ca2+ ions and being substrate for 
phosphorylation by protein kinase C (PKC), which are the hallmark characteristics of CRT. 
TAase-catalyzed protein acetylation by PAs was evidenced by the demonstration of 
immunoreactivity of the acetylated target protein, such as cytochrome P-450 reductase and nitric 
oxide synthase (NOS) with anti-acetyl lysine. The possible acetylation of human platelet NOS by 
PA as described above resulted in the enhancement of intracellular levels of nitric oxide (NO).  
PAs, unlike the parent polyphenols, exhibited NO-related physiological effects, such as 
inhibition of ADP-induced platelets aggregation. These observations, for the first time 
convincingly attribute the transacetylase function to CRT, which possibly plays an important role 
in protein modification by way of carrying auto acetylation of certain functional proteins through 
a biochemical mechanism independent of acetyl CoA.33
 
Xanthones 
 
Reactive oxygen species are primary signaling molecules in regulating the expression of 
intercellular adhesion molecule-1 (ICAM-1) on endothelial cells and hence play an important 
role in various inflammatory diseases.34,35 Xanthones are the compounds that inhibit lipid 
peroxidation and influence the generation of ROS that in turn lead to the decreased expression of 
cell adhesion molecules and subsequently decreased inflammation.35,36  The observance of these 
facts invoked us to understand the mechanisms underlying the anti-inflammatory activities of 
xanthones and for studying their structure-activity relationship. We have synthesized various 
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hydroxy, acetoxy and methoxyxanthones 8-16 (Figure 2) and studied their effect on the initiation 
of lipid peroxidation in liver microsomes to examine their antioxidant property (Table 3).37 
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Figure 2. Structures of xanthones screened. 
 
Table 3. Effect of xanthones on NADPH-dependent inhibition of lipid peroxidation initiation 
Compound 
No. 
Compound name NADPH-dependent lipid 
peroxidation initiation, 
percent of the control 
8 1-Hydroxyxanthone 28 
9 3-Hydroxyxanthone 38 
10 1,4-Dihydroxyxanthone 60 
11 2,6-Dihydroxyxanthone 43 
12 1,2-Diacetoxyxanthone 30 
13 2,6-Diacetoxyxanthone - 
14 3-Methoxyxanthone 2 
15 1,3,7-Trimethoxyxanthone 0 
16 1,5-Dihydroxy-6-methoxyxanthone - 
 
The hydroxylated xanthones showed high to moderate activity (Table 3). On the other hand, 
the dihydroxyxanthones show increased activity as compared to monohydroxy xanthones. The 
methoxylated xanthones 14, 15 and 16 did not show any appreciable inhibition of initiation of 
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lipid peroxidation. Further, the inhibition of initiation of lipid peroxidation by 1,2-
diacetoxyxanthone is comparable with 1-hydroxyxanthone 8.37 The ICAM-1 inhibitory activity 
of diacetoxy xanthones 12 and 13 may be because of in-situ enzymatic deacetylation of these 
compounds leading to the formation of the corresponding dihydroxyxanthone 11 and XII 
(Scheme 3). These in turn may be oxidized to the corresponding quinonoid xanthones XI and 
XIII, the species that may really be responsible for the observed activities. The stability of the 
ortho quinonoid xanthone XIII is less than the stability of the para-quinonoid xanthone X. 
Therefore, compound 10 exhibited maximum activity. However, the quinonoid form XIII 
derived from 12 is more stable than the charge separated quinonoid form XI derived from the 
diacetoxy xanthone 11. Surprisingly, the xanthone 16, in spite of having two hydroxy groups 
does not exhibit any noticeable activity, which may be because of the fact that this compound 
cannot oxidize, as no quinonoid structure form can be generated.  
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Scheme 3. Proposed mechanism of conversion of xanthones to their respective quinonoid forms. 
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We have demonstrated that 1,4-dihydroxyxanthone (1,4-DHX) inhibits the expression of cell 
adhesion molecules, such as ICAM-1, VCAM-1 and E-selectin, on endothelial cells in a 
concentration and time dependent manner.  The inhibition by 1,4-DHX is reversible.  On further 
analysis, it appears that 1,4-DHX inhibits the adhesion of peripheral neutrophils to the 
endothelial cell monolayers. 1,4 DHX, therefore, could be used as a novel target for controlling 
various pathological conditions associated with upregulation of endothelial leukocyte adhesion 
molecules.38  
 
Pyrazoles and Acrylonitriles 
 
In addition to coumarins and xanthones, we have studied the antioxidant activity of a new class 
of heterocyclic compounds, i.e. pyranones (lactones) 17, 5-arylpyrazoles 18, 1,3-diarylpyrazoles 
21, and acrylonitriles 19, 20 and 22 (Figure 3). Pyrazoles and their derivatives are widely used as 
medicines, e.g. antipyretic,39 anti-inflammatory,40 gastric secretion stimulatory,41 
antidepressant,42 against rheumatoid arthritis and antihypercholesterolemic agents,43 antibacterial 
agents,44 etc. This class of compounds are also useful as agrochemicals, e.g. as pesticides,45 
insecticides, in sunscreen materials, and as analytical reagents. Owing to these widespread 
applications, we have synthesized and evaluated the biological activities of pyrazoles and their 
derivatives.46  
 
Figure 3. Structures of compounds screened. 
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Table 4. Inhibitory effect of pyranones and cyanomethylpyrazoles on lipid peroxidation in rat liver 
microsomes initiated by NADPH 
 
Compound         % Inhibition of initiation             Compound           % Inhibition of initiation  
 
 17a            3               18d         27 
 17b    14   18e         33 
 17d      4   18f         10 
 17g    14   18h         18 
 17h    18   21a         33 
 18a    33   21b         33 
 18b    31   21c         26 
 18c                       35 
 
Table 5. Inhibitory effect of 2-pyrazolyl-3-(pyrrol-2-yl)acrylonitriles on lipid peroxidation in rat liver 
microsomes initiated by NADPH 
 
Compound         % Inhibition of initiation        Compound                % Inhibition of initiation 
 
19a    53   19f        42 
20a    73   20f        68 
19b    69   19g        27 
20b    95   20g        90 
19c    52   19h        77 
20c    67   20h        68 
19d    20   22a        36 
20d    62   22b        48 
19e    42   22c        87 
20e    69   22d        80 
 
We have investigated the effect of above pyranone and pyrazole derivatives at both initiation 
and propagation steps. Pyrazolylacrylonitriles have neither radical scavenging ability, nor they 
can inhibit Mixed Function Oxidase, MFO (data not shown). But, there exists the possibility of 
pyrazolylacrylonitriles forming a stable complex with ADP-perferryl radical responsible for ROS 
formation as we have shown earlier in the case of dioxygenated 4-methylcoumarins.19 NADPH-
dependent liver microsomal lipid peroxidation was assayed by the method of Ernster and 
Nordenbrand.47 The results illustrated that pyranones do not exhibit significant activity to inhibit 
the initiation of NADPH-catalyzed peroxidation of lipids of rat liver microsomes. Whereas, 
conversion of pyranones to arylpyrazoles and to 1,3-diarylpyrazoles increases the activity by 0 to 
11 fold in different cases (Tables 4 & 5). The maximum increase in activity has been observed in 
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pyrazoles with unsubstituted phenyl ring/rings derived from the corresponding pyranones. In 
addition, methyl- or methoxyphenylpyrazolylacrylonitriles are found to have better antioxidant 
activity than unsubstituted, or fluoro- or chlorosubstituted phenylpyrazolylacrylonitriles. 
 
Flavones and Isoflavones 
 
Stray ROS not only initiate lipid peroxidation in healthy cells but even the induction of human 
cancer involves a multistep process, initiated with DNA damage by endogenous reactive oxygen 
species (ROS) and exogenous activated carcinogens, followed by oncogene activation and tumor 
suppressor gene mutations, and finally lead to the alteration of different signaling pathways. 
Flavonoids are widely distributed in plants fulfilling many functions including producing yellow 
or red/blue pigmentation in flowers and protection from attack by microbes and insects. 
Flavonoids have been referred to as "nature's biological response modifiers" because of strong 
experimental evidence of their inherent ability to modify the body's reaction to allergens, viruses, 
and carcinogens. They show anti-allergic, anti-inflammatory, anti-microbial and anti-cancer 
activities. In addition, flavonoids act as powerful antioxidants, protecting against oxidative and 
free radical damage. 
We have isolated various flavones and isoflavones from natural sources, and also synthesized 
large number of these types of compounds by chemical methods. These compounds were 
subjected for anti-invasive activity evaluation. 
Invasion is the hallmark of malignant tumors, and is responsible for the bad prognosis of the 
untreated cancer patients.  The search for anti-invasive treatments led us to screen compounds of 
different classes for their effect in an assay for invasion.  Invasion of MCF-7/6 human mammary 
carcinoma cells into embryonic chick heart fragments was studied in organ culture during 8 days.  
The effect of various polyphenolic compounds, belonging to the classes of flavonoids, chalcones, 
coumarins, desoxybenzoins, aromatic ketones, etc. were tested in this assay for invasion.   
Two flavones with very similar physical behavior and spectral profile have been isolated as 
minor constituents from the seeds of Tephrosia candida.  The structures of these compounds 
have been established on the basis of a detailed and critical study of their mass spectra, extent of 
shifts in their UV spectra, X-ray diffraction studies, and prepration of their derivatives. One of 
these was the known compound, penduletin (23), while the other was a new natural compound, 
viz. 5-hydroxy-2-(4-hydroxyphenyl)-3,6,8-trimethoxy-4H-1-benzopyran-4-one (24), for which 
the name candirone was proposed (Figure 4).48  
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Figure 4. Structures of compounds isolated from Tephrosia candida. 
 
Seven compounds were isolated from the heartwood of Prunus domestica.  Two of them, 
5,7,4'-trihydroxy-3-methoxyflavanone (25) and 3,5,7-trihydroxy-6,4'-dimethoxyflavan-one (26), 
were new natural products (Figure 5).49
Three new compounds, namely 5,7-dihydroxy-6,8-dimethoxy-2-(3,5-dihydroxy-4-
methoxyphenyl)-4H-1-benzopyran-4-one (27), 5,7-dihydroxy-6-methoxy-2-(3,5-dihydroxy-4-
methoxyphenyl)-4H-1-benzopyran-4-one (28) and 5,7-dihydroxy-6-methoxy-2-(2,4-
dihydroxyphenyl)-4H-1-benzopyran-4-one (29), were isolated as an inseparable mixture from the 
aerial parts of Tamarix dioica (Figure 6).50 Two new flavones, 5,7,2'-trihydroxy-6,4'-
dimethoxyflavone (tamaridone, 30) and 5,2',4'-trihydroxy-6,7,8-trimethoxyflavone (tamadone, 
31) were also isolated from the aerial parts of Tamarix dioica, along with hexacosyl-p-
coumarate, gardenins A, B, C and E, nevadensin A and apigenin (Figure 6).51  Gardenin B (32) 
exhibited antiviral activity and anti-invasive activity against solid tumors (Figure 6).   
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Figure 5. Structures of compounds  isolated from Prunus domestica. 
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Figure 6. Structures of compounds isolated from Tamarix dioica 
 
Tangeretin (33) is a methoxyflavone from citrus fruits, which inhibits growth of human 
mammary cancer cells and cytolysis by natural killer cells (Figure 7).  Attempting to unravel the 
flavonoid's action mechanism, we found that it inhibited extracellular-signal-regulated kinases 
1/2 (ERK1/2) phosphorylation in a dose- and time-dependent manner.  In human T47D 
mammary cancer cells, this inhibition was optimally observed after priming with estradiol.  The 
spectrum of the intracellular signalling kinase inhibition was narrow and comparison of 
structural congeners showed that inhibition of ERK phosphorylation was not unique for 
tangeretin.  Our data add tangeretin to the list of small kinase inhibitors with a restricted 
intracellular inhibition profile.52 The anti-invasive activity of 3,7-dimethoxyflavone (34) was 
found at concentrations ranging from 1 to 100 µM (Figure 7). At these anti-invasive 
concentrations, no cytotoxic effects were detected: the anti-invasive effect was reversible upon 
omission of the molecule from the medium.53,54  
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Figure 7. Structures of compounds isolated from citrus fruits. 
 
Our data indicates that some polyphenolic and heterocyclic compounds are anti-invasive 
without being cytotoxic for the cancer cells.55 
 
 
Conclusions 
 
In conclusion, naturally occurring coumarins, such as 8-acetyl-7-hydroxy-6-methoxycoumarin, 
8-methoxycoumarin, trigoforin, troupin and trigocoumarin (reported several years ago as new 
natural products by us) and a wide variety of their synthetic analogues have been subjected to 
screening for inhibition of NADPH-catalysed peroxidation of rat liver microsomes which led to 
the identification of potent anti-oxidant compounds. This study may be of significance for the 
development of clinical antioxidant agents. Our study indicates the existence of a novel 
microsomal deacetylase in rat liver catalyzing deacetylation of diacetoxy-4-methylcoumarins. 
The role of a transacetylase in transferring the acetyl group of DAMC 3 and other 
acetoxycoumarins to certain functional proteins, such as NADPH cytochrome C reductase and 
nitric oxide synthase causing irreversible activation of the reductase and intracellular levels of 
nitric oxide are enunciated. 1,4-Dihydroxyxanthone (10) showed good antioxidant activity as 
well as  inhibition of the expression of cell adhesion molecules, such as ICAM-1, VCAM-1 and 
E-selectin, on endothelial cells. Methyl- or methoxyphenylpyrazolylacrylonitriles showed better 
antioxidant activity than unsubstituted, or fluoro- or chlorosubstituted 
phenylpyrazolylacrylonitriles. Also quite a few naturally occurring flavones and their synthetic 
analogues exhibited antiviral activity and anti-invasive activity against solid tumors. 
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